Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Filjack
- Development stage
- Unknown
- Lead developer
- Vanprom Lifesciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Filjack** is an oral calcium and vitamin D nutritional supplement marketed by Vanprom Lifesciences. Each tablet contains calcium citrate 1,000 mg and cholecalciferol 500 IU. Calcium citrate supplies absorbable calcium for bone mineralization, while cholecalciferol is converted to active vitamin D metabolites that promote intestinal calcium absorption through vitamin D receptor signaling. It is marketed for calcium and vitamin D deficiency and for bone-health support, including osteoporosis-related bone disorders.
- Brand names
- Filjack
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Filjack.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Filjack.